Indian markets see renewed investor interest in pharma, speciality chemicals, and exchange-traded services, with recent earnings showing mixed signals. Pharma valuations are attractive, with Sun Pharma and MNCs like GSK and Pfizer showing promise. Speciality chemicals require patience, while BSE’s performance is linked to market sentiment and NSE’s upcoming listing.
Negative Breakout: Suzlon Energy among 8 stocks that crossed below their 200 DMAs
In the Nifty500 pack, eight stocks’ closing prices crossed below their 200 DMA (Daily Moving Averages) on July 28, according to stockedge.com’s technical scan data.